Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Camcevi Etm

Generic name: Leuprolide

FDA application holder: Accord

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Camcevi Etm?
Camcevi Etm is a brand name of Leuprolide, a prescription medicine. The FDA NDC Directory lists 1 Camcevi Etm product in 1 strength and form.
Who makes Camcevi Etm?
Accord holds the FDA application for Camcevi Etm (NDA219745, approved August 25, 2025).
Is there a generic or store brand of Camcevi Etm?
Other products of Leuprolide are listed with the FDA, but none in exactly the same strength and form as a Camcevi Etm product.
Has Camcevi Etm been recalled?
No recall linked to Camcevi Etm products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Camcevi Etm is

Each Camcevi Etm product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Leuprolide · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
leuprolide mesylate 21 mg/0.3 g
injection, emulsion (subcutaneous)
Camcevi Etm None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Leuprolide →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Camcevi Etm products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA219745AccordAugust 25, 20251

Companies that list Camcevi Etm

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Camcevi Etm products.

Recalls

No recall linked to Camcevi Etm products (by their NDC code or label) appears in the FDA enforcement reports.

Next steps

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 11, 2026, retrieved November 14, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers